Clinical Trials · NCT07627074
Weight Loss in Adults Using Semaglutide (Real-world Study)
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 35,000
- Start date
- May 2026
- Locations
- 2 sites, United States, United Kingdom
- Primary endpoint
- Change in body weight